ANIMAL CELL;
ARTICLE;
CHEMICAL REACTION;
DRUG POTENCY;
DRUG RECEPTOR BINDING;
DRUG SELECTIVITY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
IC 50;
IN VITRO STUDY;
NONHUMAN;
PRIORITY JOURNAL;
STRUCTURE ANALYSIS;
Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations
Galiègue S., Mary S., Marchand J., Dussossoy D., Carrière D., Carayon P., Bouaboula M., Shire D., Le Fur G., Casellas P. (1995) Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem;232:54-61.
Distribution of cannabinoid receptor 1 (CBI) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin
Ständer S., Schmelz M., Metze D., Luger T., Rukwied R. (2005) Distribution of cannabinoid receptor 1 (CBI) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin. J Dermatol Sci;38:177-188.
Identification and functional characterization of brainstem cannabinoid CB2 receptors
Van Sickle M.D., Duncan M., Kingsley P.J., Mouihate A., Urbani P., Mackie K., Stella N., Makriyannis A., Piomelli D., Davison J.S., Marnett L.J., Di Marzo V., Pittman Q.J., Patel K.D., Sharkey K.A. (2005) Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science; 310:329-332.
SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor
Rinaldi-Carmona M., Barth F., Millan J., Derocq J., Casellas P., Congy C., Oustric D., Sarran M., Bouaboula M., Calandra B., Portier M., Shire D., Breliere J., Le Fur G. (1998) SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J Pharmacol Exp Ther;284:644-650.
In Vitro and in Vivo Pharmacological Characterization of JTE-907, a Novel Selective Ligand for the Cannabinoid CB2 Receptor
Iwamura H., Suzuki H., Ueda Y., Kaya T., Inaba T. (2000) In Vitro and in Vivo Pharmacological Characterization of JTE-907, a Novel Selective Ligand for the Cannabinoid CB2 Receptor. J Pharmacol Exp Ther;296:420-425.
Antagonists with negative intrinsic activity at δ opioid receptors coupled to GTP-binding proteins
Costa T., Herz A. (1989) Antagonists with negative intrinsic activity at δ opioid receptors coupled to GTP-binding proteins. Proc Natl Acad Sci U S A;86:7321-7325.
Involvement of cannabinoid CB(2) receptor-mediated response and efficacy of cannabinoid CB(2) receptor inverse agonist, JTE-907, in cutaneous inflammation in mice
Ueda Y., Miyagawa N., Matsui T., Kaya T., Iwamura H. (2005) Involvement of cannabinoid CB(2) receptor-mediated response and efficacy of cannabinoid CB(2) receptor inverse agonist, JTE-907, in cutaneous inflammation in mice. Eur J Pharmacol; 520:164-171.
Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors
Idris A.I., van't Hof R.J., Greig I.R., Ridge S.A., Baker D., Ross R.A., Ralston S.H. (2005) Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors. Nat Med;11:774-779.
Peripheral cannabinoid receptor, CB2, regulates bone mass
Ofek O., Karsak M., Leclerc N., Fogel M., Frenkel B., Wright K., Tam J., Attar-Namdar M., Kram V., Shohami E., Mechouolam R., Zimmer A., Bab I. (2006) Peripheral cannabinoid receptor, CB2, regulates bone mass. PNAS;103:696-701.
Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists
Lan R., Liu Q., Fan P., Lin S., Fernando S., McCallion D., Pertwee R., Makriyannis X. (1999) Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists. J Med Chem;42:769-776.
Synthesis and SAR Studies of 2-Oxoquinoline Derivatives as CB2 Receptor Inverse Agonists
Raitio K.H., Savinainen J.R., Vepsäläinen J., Laitinen J.T., Poso A., Järvinen T., Nevalainen T. (2006) Synthesis and SAR Studies of 2-Oxoquinoline Derivatives as CB2 Receptor Inverse Agonists. J Med Chem;49:2022-2027.
